Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) EBT (2017 - 2025)

Catheter Precision (VTAK) has disclosed EBT for 9 consecutive years, with -$2.3 million as the latest value for Q3 2025.

  • On a quarterly basis, EBT rose 45.0% to -$2.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$15.9 million, a 36.34% decrease, with the full-year FY2024 number at -$13.5 million, up 80.87% from a year prior.
  • EBT was -$2.3 million for Q3 2025 at Catheter Precision, up from -$6.4 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$669000.0 in Q4 2023 to a low of -$66.4 million in Q1 2023.
  • A 5-year average of -$8.0 million and a median of -$4.8 million in 2025 define the central range for EBT.
  • Peak YoY movement for EBT: plummeted 1108.37% in 2023, then soared 95.97% in 2024.
  • Catheter Precision's EBT stood at -$8.3 million in 2021, then increased by 1.53% to -$8.2 million in 2022, then soared by 91.8% to -$669000.0 in 2023, then plummeted by 271.75% to -$2.5 million in 2024, then grew by 8.89% to -$2.3 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's EBT are -$2.3 million (Q3 2025), -$6.4 million (Q2 2025), and -$4.8 million (Q1 2025).